#RespiratorySyncytialVirusDiagnosticsMarket

[technavio]

Vendor strategies in the global respiratory syncytial virus diagnostics market

The global respiratory syncytial virus diagnostics market is expected to grow at a CAGR of 9.47% during the forecast period. Major vendors in the global respiratory syncytial virus diagnostics market include Abbott, BD, bioMérieux, F. Hoffmann-La Roche, and Quidel, among others.

The increasing focus on developing technological RSV diagnostic products will result in its growing adoption. Therefore, to increase the effectiveness and efficiency of RSV diagnostics, companies are developing advanced products. Therefore, companies are developing systems and assays or reagents required for systems that are used to test for RSV. However, vendors are developing systems, which can use different assays developed by various companies.

Request for: Free Sample Report

For instance, BioGX, a manufacturer of molecular reagents, provides its reagent to BD, which can be used in the BD MAX System. in October 2016, BioGX had secured the CE-IVD marking for its Flu A, Flu B, RSV automated test on the BD MAX System. Similarly, companies are developing POC products to diagnose RSV and deliver instant results. The development of universal assays, which can be used in systems manufactured by different companies will help small- and medium-sized RSV consumable product manufacturers to increase their sales. Hence, the global respiratory syncytial virus diagnostics market is expected to grow significantly during the forecast period.